These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 7478140)

  • 1. Tumour markers in chronic renal failure and haemodialysis patients.
    Eskiocak S; Dortok H; Alvur M; Cengiz K
    Nephrol Dial Transplant; 1995; 10(7):1256. PubMed ID: 7478140
    [No Abstract]   [Full Text] [Related]  

  • 2. Serum tumour markers in patients with chronic kidney disease.
    Xiaofang Y; Yue Z; Xialian X; Zhibin Y
    Scand J Clin Lab Invest; 2007; 67(6):661-7. PubMed ID: 17852811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor marker and hemodialysis.
    Wiwanitkit V
    Saudi J Kidney Dis Transpl; 2011 Jul; 22(4):805. PubMed ID: 21743236
    [No Abstract]   [Full Text] [Related]  

  • 4. Acute effect of haemodialysis on serum markers of myocardial damage.
    Tarakçioglu M; Erbagci A; Cekmen M; Usalan C; Ciçek H; Ozaslan J; Camci C
    Int J Clin Pract; 2002 Jun; 56(5):328-32. PubMed ID: 12137438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac biomarkers and survival in haemodialysis patients.
    Sommerer C; Beimler J; Schwenger V; Heckele N; Katus HA; Giannitsis E; Zeier M
    Eur J Clin Invest; 2007 May; 37(5):350-6. PubMed ID: 17461980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of hemodialysis on levels of parathormone in blood of patients with chronic kidney failure].
    Starzyk J; Kowalski D
    Wiad Lek; 1993 Apr; 46(7-8):283-5. PubMed ID: 8249416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum tumor markers in patients on dialysis and kidney transplantation.
    Lye WC; Tambyah P; Leong SO; Lee EJ
    Adv Perit Dial; 1994; 10():109-11. PubMed ID: 7528056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum lipoprotein(a) concentration in patients with chronic renal failure receiving haemodialysis: influence of apolipoprotein (a) genetic polymorphism.
    Auguet T; Sentí M; Rubiés-Prat J; Pelegrí A; Pedro-Botet J; Nogués X; Romero R
    Nephrol Dial Transplant; 1993; 8(10):1099-103. PubMed ID: 8272223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma fibronectin concentration in patients with chronic renal failure and treated with haemodialysis.
    Eriksen HO; Tranebjaerg L; Clemmensen I; Kjersem H; Skjoldby O
    Scand J Clin Lab Invest; 1983 Dec; 43(8):723-6. PubMed ID: 6665521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimation of intake of zinc, copper and iron in the diet of patients with chronic renal failure treated by haemodialysis.
    Szpanowska-Wohn A; Kolarzyk E; Chowaniec E
    Biol Trace Elem Res; 2008 Aug; 124(2):97-102. PubMed ID: 18446276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell cholesterol transport to plasma in blood from patients with renal failure or a kidney transplant.
    Sutherland WH; Corboy J; Walker RJ; Robertson MC; Ball MJ
    Nephrol Dial Transplant; 1995; 10(3):358-65. PubMed ID: 7792031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin-converting enzyme inhibitors and higher erythropoietin requirement in chronic haemodialysis patients.
    Dhondt AW; Vanholder RC; Ringoir SM
    Nephrol Dial Transplant; 1995 Nov; 10(11):2107-9. PubMed ID: 8643177
    [No Abstract]   [Full Text] [Related]  

  • 13. [Dialysis treatment of chronic renal failure].
    Thieler H
    Zentralbl Chir; 1993; 118(3):118-21. PubMed ID: 8484283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidative stress in haemodialysis.
    Loughrey CM; Young IS; Lightbody JH; McMaster D; McNamee PT; Trimble ER
    QJM; 1994 Nov; 87(11):679-83. PubMed ID: 7820542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating N-terminal pro-brain natriuretic peptide and cardiac troponin T in chronic dialysis patients.
    Leowattana W; Ong-Ajyooth L; Taruangsri P; Pokum S
    J Med Assoc Thai; 2003 May; 86 Suppl 1():S52-8. PubMed ID: 12866769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two years' experience with the chronic intermittent haemodialysis program (CHIHP) in patients with chronic renal failure.
    Erben J; Krch V; Macek J; Kvasnicka J; Bartos V; Bastecký J; David I
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1969; 12(5):571-8. PubMed ID: 5267594
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluation of thyroid hormones in chronic renal failure.
    Xess A; Gupta A; Kumar U; Sharma HP; Prasad KM
    Indian J Pathol Microbiol; 1999 Apr; 42(2):129-33. PubMed ID: 10639771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Arterial hypertension in patients on chronic hemodialysis].
    Zogović J; Mladenović Lj
    Srp Arh Celok Lek; 1996; 124(9-10):246-50. PubMed ID: 9102857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of dialysis on phagocytic activity in patients with chronic kidney failure].
    Lisý Z
    Vnitr Lek; 1979 Jun; 25(6):555-9. PubMed ID: 462825
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of hemodialysis on lipid peroxidation and antioxidant system in patients with chronic renal failure.
    Mohora M; Mircescu G; Cîrjan C; Mihăilescu I; Gîrneaţă L; Ursea N; Dinu V
    Rom J Intern Med; 1995; 33(3-4):237-42. PubMed ID: 8646196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.